Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
182.18
-1.05 (-0.57%)
At close: Oct 24, 2025, 4:00 PM EDT
181.01
-1.17 (-0.64%)
After-hours: Oct 24, 2025, 7:51 PM EDT
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 15 analysts that cover Quest Diagnostics stock have a consensus rating of "Buy" and an average price target of $194.07, which forecasts a 6.53% increase in the stock price over the next year. The lowest target is $172 and the highest is $215.
Price Target: $194.07 (+6.53%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 7 | 7 | 8 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $190 → $195 | Hold | Maintains | $190 → $195 | +7.04% | Oct 22, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $195 → $205 | Hold | Maintains | $195 → $205 | +12.53% | Oct 22, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $203 → $210 | Buy | Maintains | $203 → $210 | +15.27% | Oct 21, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $200 → $215 | Strong Buy | Maintains | $200 → $215 | +18.02% | Oct 21, 2025 |
| UBS | UBS | Hold Maintains $180 → $190 | Hold | Maintains | $180 → $190 | +4.29% | Oct 17, 2025 |
Financial Forecast
Revenue This Year
10.98B
from 9.87B
Increased by 11.17%
Revenue Next Year
11.36B
from 10.98B
Increased by 3.48%
EPS This Year
9.85
from 7.69
Increased by 28.05%
EPS Next Year
10.44
from 9.85
Increased by 6.07%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.5B | 12.0B | |||
| Avg | 11.0B | 11.4B | |||
| Low | 10.6B | 10.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.4% | 9.4% | |||
| Avg | 11.2% | 3.5% | |||
| Low | 7.3% | -0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.31 | 11.22 | |||
| Avg | 9.85 | 10.44 | |||
| Low | 9.47 | 9.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 34.1% | 14.0% | |||
| Avg | 28.0% | 6.1% | |||
| Low | 23.2% | -2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.